Press release
Metagenomics Market Report 2024: Strategies And Recent Developments | Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc.
Metagenomics Market Characteristics
The Business Research Company offers in-depth market insights through Metagenomics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The metagenomics market size has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to microbiome research advancements, disease association studies, environmental monitoring needs, agricultural and food applications, biotechnology and industrial processes..
The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $3.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations.. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp
Market Segmentation:
The metagenomics market covered in this report is segmented -
1) By Product: Instruments, Kits And Reagents, Software And Services
2) By Workflow: Sequencing, Pre-Sequencing, Data Analysis
3) By Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications
4) By End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes
Major Driver - The Impact Of Rising Infectious Disease Incidence On The Metagenomics Market
The rise in the incidence of infectious diseases is significantly contributing to the growth of the metagenomics market. Infectious diseases, also known as transmissible diseases, refer to illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, and can be transmitted from person to person or through other modes of transmission. Metagenomics is used to study infectious diseases by analyzing the genetic material of microbial communities. It allows for the comprehensive analysis of microbial communities associated with infectious agents, providing insights into their composition, genetic diversity, and potential interactions. For instance, in October 2022, according to an article published by the Pan American Health Organization, a US-based specialized agency of the United Nations, approximately 10.6 million people fell ill with tuberculosis (TB) in 2021. Therefore, the increasing prevalence of infectious diseases is driving the growth of the metagenomics market.
Competitive Landscape:
Major companies operating in the metagenomics market report are Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Takara Bio USA Inc., BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report
Top Trend - The Impact Of Technological Advancements On The Metagenomics Market
Technological advancements are the key trend gaining popularity in the metagenomics market. Major companies operating in the metagenomics market are focused on adopting new genomics technologies to improve their observation power and sustain their position in the market. For instance, in May 2023, CD Genomics, a US-based genomics services company, launched the Long-Read Metagenomic Sequencing service. With its state-of-the-art technology, researchers and scientists are better equipped to understand the complexity of microbial communities with unmatched accuracy and depth. Clients can enter a new era of metagenomics research by utilizing CD Genomics' cutting-edge technology and genomic knowledge. Its key features include enhanced resolution, species identification, functional annotation, and comparative analysis. This advanced method is expected to transform metagenomics research by offering previously unattainable insights into microbial communities.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Metagenomics Market Characteristics
3. Metagenomics Market Trends And Strategies
4. Metagenomics Market - Macro Economic Scenario
5. Metagenomics Market Size And Growth
…..
27. Metagenomics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metagenomics Market Report 2024: Strategies And Recent Developments | Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc. here
News-ID: 3430773 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Metagenomi
Cell Engineering Service Market Set to Grow Steadily Through 2025, Key Trends, R …
QY Research has recently published a research report titled, "Global Cell Engineering Service Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Cell Engineering Service market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help…
2025-2034 Base-Editing Tools Market Evolution: Disruptions, Innovations, and Unt …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Base-Editing Tools Market Through 2025?
In recent times, the market size for base-editing tools has seen a staggering growth. Expected to expand from $1.50 billion in 2024 to $1.83 billion in 2025, it's forecasted to boast a compound annual growth rate (CAGR)…
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over…
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024.
Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.…
